BioSpace News Archive

In response to the recently released surprise billing proposals from the House Ways and Means, the American College of Emergency Physicians released the following statement

Eisai announced the presentation of three abstracts at the 2020 Genitourinary Cancers Symposium in San Francisco from February 13-15.

Sirnaomics, Inc., a leading biopharmaceutical company in discovery and development of RNAi therapeutics, announced that the Office of Orphan Product Development division of the FDA has granted orphan drug designation to its leading therapeutic candidate, STP705, for the treatment of Hepatocellular Carcinoma.

Collegium Pharmaceutical, Inc. announced the pricing of its offering of $125,000,000 aggregate principal amount of 2.625% convertible senior notes due 2026 in a public offering registered under the Securities Act of 1933, as amended.

Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Portola Pharmaceuticals, Inc. between November 5, 2019 and January 9, 2020, inclusive, of the important March 16, 2020 lead plaintiff deadline in the securities class action.

Luye Pharma Group has announced that it has entered into an exclusive distribution and marketing service agreement with Cipla Medpro South Africa Limited, for Seroquel® and Seroquel XR® in South Africa, Namibia and Botswana.

Seelos Therapeutics, Inc. announced the pricing of an underwritten public offering of 6,666,667 shares of its common stock, at a price to the public of $0.75 per share.

Further to my previous statements, as Chief Public Health Officer, I have assessed additional individuals in quarantine at Canadian Forces Base Trenton pursuant to an Emergency Order under the Quarantine Act and determined that they do not pose a risk of significant harm to public health.